Cholestasis is a bile flow reduction that is induced following Bile Duct
Ligation (BDL).
Cholestasis impairs memory and induces apoptosis. Apoptosis consists of two pathways: intrinsic and extrinsic. The intrinsic pathway is modulated by BCL-2 (
B cell lymphoma-2) family
proteins. BCL-2 (a pro-survival BCL-2
protein) has anti-apoptotic effect, while BAD (BCL-2-associated death) and BAX (BCL-2-associated X), the other members of BCL-2 family have pro-apoptotic effect. Furthermore, TFAM (mitochondrial transcriptional
factor A) is involved in transcription and maintenance of
mitochondrial DNA and PGC-1α (
peroxisome proliferator-activated receptor γ coactivator-1α) is a master regulator of mitochondrial biogenesis. On the other hand,
NeuroAid is a
Traditional Chinese Medicine with neuroprotective and anti-apoptosis effects. In this study, we evaluated the effect of
cholestasis on spatial memory and expression of BCL-2, BAD, BAX, TFAM, and PGC-1α in the hippocampus of rats. Additionally, we assessed the effect of
NeuroAid on
cholestasis-induced cognitive and genetic alterations.
Cholestasis was induced by BDL surgery and
NeuroAid was injected intraperitoneal at the dose of 0.4 mg/kg. Furthermore, spatial memory was evaluated using Morris Water Maze (MWM) apparatus. The results showed
cholestasis impaired spatial memory, increased the expression of BAD and BAX, decreased the expression of TFAM and PGC-1α, and did not alter the expression of BCL-2. Also,
NeuroAid decreased the expression of BAD and BAX and increased the expression of TFAM, PGC-1α, and BCL-2. In conclusion,
cholestasis impaired spatial memory and increased the expression of pro-apoptotic genes. Also,
cholestasis decreased the expression of TFAM and PGC-1α. Interestingly,
NeuroAid restored the effects of
cholestasis.